Lonza Group AG
LSE:0QNO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lonza Group AG
LSE:0QNO
|
CH |
|
Z
|
Zodiac-JRD-MKJ Ltd
BSE:512587
|
IN |
|
China Construction Bank Corp
F:C6TB
|
CN |
|
D
|
Deutsche Post AG
XMUN:DHL
|
DE |
|
Praemium Ltd
ASX:PPS
|
AU |
|
Peppermint Innovation Ltd
ASX:PIL
|
AU |
Intrinsic Value
Is 0QNO undervalued or overvalued?
See the intrinsic value estimate for 
Lonza Group AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Lonza Group Does
Lonza Group AG is a life sciences company that makes and supplies ingredients, materials, and manufacturing services used in medicines and other health products. It does not sell to ordinary consumers; instead, it works behind the scenes for drug makers, biotech companies, and healthcare customers that need help developing or producing complex products.
- Headquarters
- Switzerland CH
- Employees
- 20 000
- IPO date
- Apr 3, 2002
Lonza Group has no economic moat
Rival manufacturers can offer drugmakers alternative production facilities and technical expertise, so Lonza cannot rely on its size alone to keep competitors out. Its established capabilities help it compete, but do not give it exclusive access to customers or drug-manufacturing markets.
Read the full moat analysis
Earnings Waterfall
Lonza Group AG
The intrinsic value for Lonza Group AG (0QNO) under the Base Case is hidden CHF.
Compared with the current market price of 652.2 CHF, the stock appears hidden.
